| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |